|
2017
|
Invention
|
Process for the preparation of (3s,4s)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3h-imidazo[4,... |
|
2016
|
Invention
|
(r)-carbidopa alone or in combination with a steroid for treating pain, inflammation, an inflamma... |
|
|
Invention
|
New therapeutic compound and use in therapy. {4-[3-(Dimethylamino)propoxy]phenyl}methyl (4S)-4-(p... |
|
|
Invention
|
Treatment of pain.
(3S)-Tetrahydrofuran-3-yl(4S)-4-isopropyl-1,4,6,7-tetrahydro-5H-imidazo[4,5-c... |
|
|
Invention
|
Pharmaceutical salt forms of an inhibitor of semicarbazide-sensitive amine oxidase (ssao). The me... |
|
|
Invention
|
Crystalline compound as semicarbazide-sensitive amine oxidase (ssao) enzyme inhibitor. A specific... |
|
|
Invention
|
Treatment of pain. (3S)-Tetrahydrofuran-3-yl(4S)-4-isopropyl-1,4,6,7-tetrahydro-5H-imidazo[4,5-c]... |
|
|
Invention
|
Novel therapies for cancer. The invention relates to 6-{4-[1 -(Propan-2-yl)piperidin-4-yl]-1,4-di... |
|
|
Invention
|
Pro-drug compounds.
The present invention provides neuronal gap junction blocking compounds acco... |
|
2015
|
Invention
|
Therapeutic uses of enzyme inhibitors.
The invention relates to use of compounds which inhibit V... |
|
|
Invention
|
Imidazo[4,5-c]pyridine derived ssao inhibitors. A compound of formula (I) or a pharmaceutically a... |
|
|
Invention
|
Imidazo[4,5-c]pyridine derived ssao inhibitors. A compound as set out in claim 1, and the use of ... |
|
|
Invention
|
Cxcr4 receptor antagonists.
The compounds of formula (I) are antagonists of the CXCR4 receptor
... |
|
|
Invention
|
Imidazopyridine compounds.
The invention relates to compounds of formula (I): and their pharmace... |
|
|
Invention
|
New compounds.
The present invention provides certain compounds according to formula (I) which a... |
|
2014
|
Invention
|
Tonabersat prodrugs.
The invention relates to pharmaceutically active compounds having improved ... |
|
|
Invention
|
Prodrug compounds. A compound of formula (Ia) or (Ib), or a pharmaceutically acceptable salt ther... |
|
|
Invention
|
Tonabersat prodrugs. The invention relates to pharmaceutically active compounds having improved p... |
|
|
Invention
|
Vap-1 inhibitors for treating muscular dystrophy. The invention relates to the use of compounds w... |
|
|
Invention
|
Indole derivative modulators of the alpha 7 nachr.
This invention relates to modulation of the α... |
|
|
Invention
|
Drug combination and its use in therapy of obesity and type ii diabetes. A product comprising: (i... |
|
|
Invention
|
Drug combination and its use in therapy of obesity. A product comprising: (i) (2R)-Methyl-1-{3-[2... |
|
|
Invention
|
New therapeutic uses of enzyme inhibitors.
The invention relates to use of compounds which inhib... |
|
|
Invention
|
New therapeutic uses of enzyme inhibitors. The invention relates to use of compounds which inhibi... |
|
|
Invention
|
Indole and azaindole modulators of the alpha 7 nachr.
This invention relates to modulation of th... |
|
|
Invention
|
(2r)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine and salts thereof.
The present invention relate... |
|
|
Invention
|
Prx933 (prx-00933), a 5ht2c agonist, for use in the treatment of hypertension. The use of PRX933 ... |
|
|
Invention
|
Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as ssao inhibitors. The compounds o... |
|
|
Invention
|
New compounds. The compound of formula (I) are inhibitors of SSAO activity (Formula (I)) wherein ... |
|
|
Invention
|
Imidazopyridine compounds.
A method of treating inflammation, an inflammatory disease, an immune... |
|
2013
|
Invention
|
Pro-drug compounds.
A compound according to formula (I) or a hydrate, solvate, or pharmaceutical... |
|
|
Invention
|
Pro-drug compounds. A compound according to formula (I) or a hydrate, solvate, or pharmaceuticall... |
|
|
Invention
|
New compounds ii.
The present invention relates to compounds of formula (I),
The present inven... |
|
|
Invention
|
Par2 receptor antagonists. Compounds of formula (I) or pharmaceutically acceptable salts, solvate... |
|
|
Invention
|
Receptor antagonists. N-(4-carbamimidoylphenyl)-amide derivatives having utility in therapy as PA... |
|
|
Invention
|
Pro-drug compounds. 1 are as defined in the claims.
|
|
|
Invention
|
Pro-drug compounds.
A compound of formula (I), or a pharmaceutically acceptable salt thereof:
... |
|
|
Invention
|
Pro-drug compounds. A compound of formula (I), or a pharmaceutically acceptable salt thereof: whe... |
|
2012
|
Invention
|
New enzyme inhibitor compounds.
Compounds of formula (I) are inhibitors of Semicarbazide-sensiti... |
|
|
Invention
|
Protease activated receptor 2 (par2) antagonists.
A compound of formula (I) or a pharmaceuticall... |
|
2011
|
Invention
|
Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive ... |
|
|
Invention
|
Enzyme inhibitor compounds. 2-{4-[1-(4-chlorophenyl)-1H-pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl... |
|
2009
|
Invention
|
Novel treatments.
The present invention relates to the treatment or prevention of disorders wher... |
